Shepherd Kaplan Krochuk, LLC Myovant Sciences Ltd. Transaction History

Shepherd Kaplan Krochuk, LLC

  • $127 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$19.2 - $25.14 $223,430 - $292,554
-11,637 Closed
0 $0
Q1 2018

May 11, 2018
SELL
$12.46 - $21.32 $20,733 - $35,476
-1,664 Reduced 12.51%
11,637 $248,000
Q4 2017

Feb 13, 2018
BUY
$11.37 - $16.4 $151,232 - $218,136
13,301
13,301 $168,000

Others Institutions Holding MYOV

# of Institutions
6
Shares Held
61.3K
Call Options Held
0
Put Options Held
0
View Full List

About Myovant Sciences Ltd.

MYOV Quotes by TradingView
  • Ticker MYOV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 96,802,800
  • Description
  • Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...
More about MYOV
Track This Portfolio

Track Shepherd Kaplan Krochuk, LLC Portfolio

Follow Shepherd Kaplan Krochuk, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shepherd Kaplan Krochuk, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shepherd Kaplan Krochuk, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email